Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity Post author:Sam Post published:July 31, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen November 21, 2017 Novartis AG to Lay Off 250 Nationwide, With 204 from New Jersey U.S. Headquarters May 23, 2017 Ohr Pharma Suspends Work at San Diego Lab February 23, 2017